Bliss GVS Pharma Q2 profit up 22 Percent to Rs 41.45 crore
NEW Delhi: Bliss GVS Pharma on has reported a 22 per cent increase in consolidated profit to Rs 41.45 crore in the second quarter ended September 30, 2018. Bliss GVS Pharma had posted a profit of Rs 33.98 crore in the same period a year ago.
Bliss GVS Pharma is an Indian pharmaceutical and company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others
Total income of the company increased by 4.8 per cent to Rs 253.3 crore from Rs 241.7 crore during the period under review.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd